Top Non-Pharmacological Therapies for Alleviating Knee Osteoarthritis Pain

Knee braces appear to effectively alleviate the symptoms of osteoarthritis impacting the joints

Tom Werner/Getty Images

Knee braces and water-based exercises are among the most effective techniques for alleviating pain and stiffness associated with knee osteoarthritis. High-quality evidence is necessary before these methods can be universally recommended in clinical practice, as indicated by reviews of 12 non-pharmacological therapies.

This condition arises from the deterioration of cartilage, which cushions the edges of bones, leading to inflammation, discomfort, and stiffness. Pain relief medications and anti-inflammatory drugs can ease these symptoms, but side effects may occur, so healthcare providers often recommend physical therapy, such as shoe inserts to reduce knee pressure, tape for joint support, or laser therapy aimed at encouraging cartilage repair.

However, it remains uncertain how these treatments compare to one another. “Many reviews of treatments focus solely on the efficacy of individual therapies,” states Sarah Kingsbury, who was not part of the recent research conducted at the University of Leeds in the UK.

To address this gap, Yuan Luo from China’s First People’s Hospital and colleagues evaluated data from 139 randomized controlled trials examining 12 approved or experimental physiotherapy approaches for knee osteoarthritis. These trials included over 9,600 adults suffering from this condition.

Some studies compared two or three physical therapies, while others investigated one therapy against either a placebo or no treatment at all. Participants typically underwent treatment for several weeks before completing a symptom assessment.

Based on their findings, researchers concluded that knee braces effectively diminish pain and stiffness, emerging as the top method for enhancing mobility, followed by water-based exercise. “When you’re walking in a pool, you engage your muscles without stressing the joints in the same way walking in a park would,” says Kingsbury.

The ranking of efficacy for the other tested treatments is as follows: high-energy laser therapy, which delivers high-energy sound waves into the knee; low-energy laser therapy, which applies electrical stimulation to knee nerves; taping the knee; electromagnetic stimulation; ultrasound treatment; and wearing insoles.

Due to various factors, the findings are insufficiently robust to change clinical practices, Kingsbury notes. Many studies involved fewer than 50 participants, resulting in a limited sample size that can undermine confidence in the results. Additionally, treatment durations varied widely, from one week to less than a few months, which may skew perceptions of effectiveness.

Another limitation is that these studies did not juxtapose physical therapy with drug treatments or evaluate the efficacy of combining pharmaceutical and non-pharmaceutical interventions, Kingsbury points out.

Despite these limitations, the reviews offer valuable insights regarding the most effective approaches, she suggests. “Establishing this ranking is useful and crucial. It allows us to possibly exclude the least effective 6 to 10 therapies, enabling us to focus on strengthening the evidence surrounding a few selected treatments.”

Topic:

Source: www.newscientist.com

Migraine Medications Are Ineffective in Alleviating Dizziness Symptoms

Here’s a rewritten version of your content while keeping the HTML tags intact:

Rizatriptan is frequently recommended for various migraine types

Aleksandr Zubkov/Getty Images

The standard medications prescribed for migraines provide limited relief for the vestibular symptoms, which include dizziness and typical migraine manifestations like headaches and light sensitivity. This is true even for rizatriptan, which is sometimes recommended for such types of migraines.

Research on vestibular migraine treatment has been inconsistent, yielding mixed results across different medications, according to Jeffrey Staab from the Mayo Clinic in Rochester, Minnesota. Some newer medications, like galcanezumab, may reduce the frequency of attacks, but no randomized trials have previously evaluated the effectiveness of migraine medications in alleviating vestibular symptoms during episodes.

To fill this research gap, Staab and his team investigated vestibular migraines. Participants were instructed to take 10 milligrams of rizatriptan or a placebo at the onset of vestibular symptoms, such as balance problems and spinning sensations. Their symptoms were subsequently evaluated on a scale of 0 to 3 at several intervals until the episodes resolved.

One hour after administration—at which point rizatriptan reaches peak concentrations in the bloodstream—it was not more effective than the placebo in relieving symptoms which are often considered to act quickly. Both groups were allowed to use back-up medications after waiting the necessary hour.

After 24 hours, rizatriptan showed a slight improvement in sensitivity to movement, light, and sound, but not in dizziness. Participants also reported marginally higher scores concerning physical well-being—such as energy levels and the ability to carry out daily activities—when compared to those taking the placebo. However, no differences were noted in mental well-being or the acceptance of side effects.

Rizatriptan falls under the triptans class of drugs, typically effective against migraines, but may not alleviate vestibular symptoms, as noted by Staab.

The study’s findings indicate that the brain pathways linked to vestibular migraines (the vestibular system, which is considered “primitive” from an evolutionary standpoint) may lack sensitivity to triptans for reasons that are yet to be explored. According to Peter Goadsby from King’s College London, vestibular migraines should not be treated as distinct conditions from other migraine types; rather, their symptoms represent a “slight variation” of migraine pathology that necessitates targeted treatment approaches.

“I think it’s important to communicate with fellow clinicians about these symptoms,” Goadsby states. “For instance, if you are treating someone with a vestibular migraine using a triptan, be prepared for it to potentially be ineffective. It’s crucial to recognize that this doesn’t imply the patient is difficult or unreasonable.”

Topics:

This retains the original HTML structure while rephrasing the content for clarity and flow.

Source: www.newscientist.com

Breakthrough App Shows Promise in Alleviating Tinnitus Symptoms

Tinnitus, a ringing in the ears, can be a debilitating problem for those who suffer from it. However, a team of researchers has discovered a potential solution to this issue.

The survey results have been published in the magazine Frontiers of audiology and otology, and an international research team can effectively reduce symptoms in just a few weeks with an app that includes sound therapy and various training courses. The study involved 30 people with tinnitus, and almost two-thirds of them experienced “clinically significant improvement” from using the app. The team will now conduct a large-scale trial in the UK in collaboration with University College London Hospital. According to Suzanne Purdy, Waipapa Taumata Rau Professor of Psychology at the University of Auckland, New Zealand, cognitive behavioral therapy is known to help people suffering from tinnitus, but it is expensive and often difficult to access.



“[The app] Cognitive behavioral therapy, mindfulness, relaxation exercises, and sound therapy can be combined to train your brain’s responses and reduce tinnitus. The sounds you perceive fade into the background and become less noticeable.”

The new app aims to tune out the sound of tinnitus, giving the mind and body tools to suppress stress hormones and responses, and reduce the brain’s tendency to focus on the sound. The Mindear app is currently available for download for Apple and Android users. Some features are free in the app, but many are locked behind a paywall after a 7-day free trial (requires a £13 monthly subscription). Another app, the sound tinnitus app, is currently undergoing clinical trials in the UK.

About 1.5 million people in Australia, 4 million in the UK and 20 million in the US suffer from severe tinnitus, according to Dr. Fabrice Bardy, an audiologist at Waipapa Taumata Rau, University of Auckland, and lead author of the study published in the journal Frontiers of audiology and otology. He adds, “One of the most common misconceptions about tinnitus is that there’s nothing you can do about it; you just have to live with it. This is simply not true. Tinnitus Support Expertise The support of professionals with knowledge and expertise can reduce the fear and anxiety associated with a healthy patient experience.”

Tinnitus itself is not a disease, but is usually a symptom of another underlying health condition, such as damage to the auditory system or tension in the head and neck. While there is no known cure for tinnitus, management strategies and techniques can help patients. For more information, please visit the provided links.

Source: www.sciencefocus.com